Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin prophylaxis versus placebo for uncomplicated non-mesh inguinal herniorrhaphy
PACTR202511774848151Not yet recruiting
- Sponsor
- Université Catholique du Graben
- Start
- Jan 2026
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of cefazolin and Placebo-COD Research Private Ltd in surgical site infection (SSI) (2 arms), sponsored by Université Catholique du Graben. Primary endpoint: Surgical site infection within 30 days. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
cefazolinPlacebo-COD Research Private Ltd
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on PACTR202511774848151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511774848151.